Insights On Regulatory Compliance

  1. Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors 6/15/2026

    Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.

  2. What Pharmacies Often Miss In USP <800> Compliance 5/27/2026

    Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.

  3. Moving Beyond OEE To Operational Intelligence 4/17/2026

    OEE provides a high-level view of equipment performance, but it doesn’t explain the root causes. Learn why manufacturers need deeper insight to turn utilization metrics into meaningful improvements.

  4. Overcoming Excipient Risks And Challenges For Parenteral Formulations 8/27/2025

    Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

  5. Protect Your Columns And Your Peaks 2/24/2026

    Learn how thoughtful filter selection can protect LC systems, improve protein recovery, and support reliable chromatographic results with key performance data and solvent compatibility insights.

  6. The Influence Of Economic Factors On Biopharmaceutical Manufacturing 4/16/2025

    Understanding the complex effects of inflation, recession, and regulatory shifts is key to navigating the challenges faced by the biopharmaceutical manufacturing sector and ensuring its continued growth.

  7. De-Risking Automatic Visual Inspection (AVI) Through Integrated Validation 7/30/2026

    Aligning visual inspection systems with site standards prevents costly validation failures. Discover strategies to de-risk equipment startup.

  8. Annex 1 FAQs: How Do You Understand Risk Regarding Contamination Control? 5/11/2026

    True Annex 1 compliance requires a facility-wide contamination-control culture. Discover how rigorous risk awareness shapes behavior at every touchpoint across a manufacturing environment.

  9. Modernizing Your Way To Success In Cell And Gene Therapy Manufacturing 7/24/2025

    Cell and gene therapy has evolved from a niche concept to a booming sector in just five years, with over 1,300 companies and growing momentum in innovation, investment, and regulatory approvals.

  10. The Benefits Of Low Endotoxin Products 6/16/2025

    Minimizing endotoxin contamination is vital in manufacturing to protect patients. Learn more about rigorously tested, low-endotoxin products designed for critical cleanroom and sterile applications.